These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9007586)

  • 1. Prevalence of antibodies against HEp-2 cell antigen in infants and children hospitalized with respiratory syncytial virus infection.
    Forster J; Maier O; Löbbert J; Kaufmehl K; Streckert HJ; Werchau H
    Infection; 1996; 24(6):407-11. PubMed ID: 9007586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection.
    Yamazaki H; Tsutsumi H; Matsuda K; Nagai K; Ogra PL; Chiba S
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():2115-9. PubMed ID: 8046418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients.
    Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Henke DM; Patel KD; Piedra FA; Angelo LS; Shah DP; Chemaly RF; Piedra PA
    Viruses; 2021 May; 13(6):. PubMed ID: 34073490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune response of small children by antibodies of different classes to respiratory syncytial virus (RSV) proteins.
    Wilczyński J; Lukasik B; Torbicka E; Tranda I; Brzozowska-Binda A
    Acta Microbiol Pol; 1994; 43(3-4):369-79. PubMed ID: 7740987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus infection in hospitalized patients and healthy children in El Salvador.
    Colocho Zelaya EA; Pettersson CA; Forsgren M; Orvell C; Strannegard O
    Am J Trop Med Hyg; 1994 Nov; 51(5):577-84. PubMed ID: 7985749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of human antibodies against linear antigenic and immunogenic regions of respiratory syncytial virus (RSV) nucleocapsid and phospho-proteins shows the site-directed characteristics.
    Leonova IV; Leonov SV; Waris M; Russi JC; Grandien M; Norrby E
    J Clin Virol; 1998 Aug; 11(2):137-47. PubMed ID: 9785215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age.
    Jans J; Wicht O; Widjaja I; Ahout IM; de Groot R; Guichelaar T; Luytjes W; de Jonge MI; de Haan CA; Ferwerda G
    PLoS One; 2017; 12(1):e0170877. PubMed ID: 28135305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancement.
    Tristram DA; Welliver RC; Hogerman DA; Hildreth SW; Paradiso P
    Vaccine; 1994 May; 12(6):551-6. PubMed ID: 8036830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the human serological immune response to a variable region of the attachment (G) protein of respiratory syncytial virus during primary infection.
    Cane PA; Thomas HM; Simpson AF; Evans JE; Hart CA; Pringle CR
    J Med Virol; 1996 Mar; 48(3):253-61. PubMed ID: 8801286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
    Shinoff JJ; O'Brien KL; Thumar B; Shaw JB; Reid R; Hua W; Santosham M; Karron RA
    J Infect Dis; 2008 Oct; 198(7):1007-15. PubMed ID: 18702606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection.
    Capella C; Chaiwatpongsakorn S; Gorrell E; Risch ZA; Ye F; Mertz SE; Johnson SM; Moore-Clingenpeel M; Ramilo O; Mejias A; Peeples ME
    J Infect Dis; 2017 Dec; 216(11):1398-1406. PubMed ID: 29029312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection.
    Piedra PA; Glezen WP; Kasel JA; Welliver RC; Jewel AM; Rayford Y; Hogerman DA; Hildreth SW; Paradiso PR
    Vaccine; 1995 Aug; 13(12):1095-101. PubMed ID: 7491817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies.
    Piedra PA; Jewell AM; Cron SG; Atmar RL; Glezen WP
    Vaccine; 2003 Jul; 21(24):3479-82. PubMed ID: 12850364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.
    Tripp RA; Moore D; Winter J; Anderson LJ
    J Virol; 2000 Feb; 74(4):1614-22. PubMed ID: 10644330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The humoral immune response of children and infants to an RSV infection: its maturation and association with illness.
    Forster J; Streckert HJ; Werchau H
    Klin Padiatr; 1995; 207(6):313-6. PubMed ID: 8569131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of respiratory syncytial virus (RSV) antigen in the lungs of guinea pigs 6 weeks after experimental infection and despite of the production of neutralizing antibodies.
    Streckert HJ; Philippou S; Riedel F
    Arch Virol; 1996; 141(3-4):401-10. PubMed ID: 8645083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique.
    Roca A; Abacassamo F; Loscertales MP; Quintó L; Gómez-Olivé X; Fenwick F; Saiz JC; Toms G; Alonso PL
    J Med Virol; 2002 Aug; 67(4):616-23. PubMed ID: 12116014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
    Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
    J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of antibody against contemporary virus lineages of human respiratory syncytial virus sub-group A in infants and their mothers.
    McGill A; Greensill J; Craft AW; Fenwick F; Toms GL
    J Clin Virol; 2004 May; 30(1):73-80. PubMed ID: 15072758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.